Welcome to Kidney Week 2019 in Washington D.C.
 

At Fresenius Medical Care North America (FMCNA), we are excited to be in our nation’s capital and to support the government’s commitment to reducing the progression of CKD, and to opening new pathways to kidney transplantation and home dialysis therapies. We are very pleased to work together to transform kidney care for the future and we invite you to join us.

Our many poster and oral presentations reveal new insights, from artificial intelligence to vascular access, that we hope will help to substantially improve how we deliver care. Our trade booths display the latest innovations designed to improve patient outcomes whether through home technologies, connected health platforms, new dialyzers, fluid monitoring, or improved water filtration.

Our merger with NxStage has enhanced FMCNA, with new people, ideas, and solutions. We have seen our growth rate for home therapies in 2019 increase to be eight times that of in-center treatment. Our Fresenius Medical Care Foundation recently announced a substantial and meaningful partnership with Donate Life America to establish a national living donor registry and testing kit.

This is truly an exciting moment in the history of kidney care in the United States. Please join us as we continue our work to improve the lives of every patient, every day. We are excited to work together to achieve positive change. 

Robert J. Kossmann, MD, FACP, FASN
Chief Medical Officer
Fresenius Medical Care North America

Stop by for a Chat
 

  • Empowering Dialysis Care

    Renal Therapies Group (RTG) is passionately committed to helping people with end stage renal disease (ESRD) lead more active and fulfilling lives. Through its medical device and pharmaceuticals division, RTG delivers hemodialysis and peritoneal dialysis equipment, as well as renal pharmaceuticals, in support of the clinical and home environments.

    Product Showcase at ASN
     

    AquaBplus & AquaC UNO H Dialysis Water Systems 

    Discover the next generation of reverse osmosis water systems offering flexibility, cost effectiveness, remote monitoring, and automated features.   

    LEARN MORE ABOUT DIALYSIS WATER SYSTEMS

    Optiflux® Dialyzers    

    500 million treatments and counting. See how we’re building on the proven capability of Optiflux® with new innovations. Visit us at ASN.    

    Velphoro (sucroferric oxyhydroxide) chewable tablets   
    Visit Us at Booth #1305

    Real World Results.  See Indication and Important Safety Information

    LEARN MORE ABOUT VELPHORO

    © 2019, Fresenius Medical Care. All Rights Reserved. Fresenius Medical Care triangle logo, and Optiflux are trademarks of Fresenius Medical Care Holdings, Inc or its affiliated companies. All other trademarks are the property of their respective owners. Velphoro is made in Switzerland and distributed by Fresenius Medical Care North America. P/N 103952-01 Rev A 10/2019    

  • High-Quality, Personalized Kidney Care
    Fresenius Kidney Care is the worldwide leader in the treatment of renal disease. Serving over 190,000 patients in over 2,400 facilities nationwide, we are focused on the physical and emotional aspects of kidney disease. Offering personalized care, education, and lifestyle support while empowering your patients with connected health technology, we are giving you and our care teams more timely health data on your patients. With a holistic approach to patient care, we are committed to reducing the overall cost of care and helping your patients live longer, healthier lives…
    and thrive.

  • Experience the Difference
    Spectra delivers unparalleled renal-specific testing, analysis, and reporting to ensure reliable results. Its leading team of clinical experts provides guidance to renal professionals and is equipped with patient-centric tools and resources to help you meet and exceed industry guidelines.

  • Redefining Dialysis, Individualizing Care
    NxStage is transforming home dialysis therapy, manufacturing innovative products for treating end stage renal disease (ESRD). 

    A growing body of evidence supports prescribing more frequent home treatments (peritoneal dialysis and home hemodialysis) to improve the quality of life of the increasing ESRD patient population and remove the constraints of conventional in-center dialysis. With home dialysis, clinicians can tailor treatments to meet the specific needs of each patient. When patients feel better, they live better.

    Product Showcase at ASN
     

    Liberty® Select Cycler 2.9 

    New product features for the Liberty Select Peritoneal Dialysis Cycler, manufactured by Fresenius Medical Care Renal Therapies Group, have arrivedFewer alarms and custom therapy options are now available.   

    DISCOVER LIBERTY SELECT 2.9

    NxStage Home Hemodialysis

    The NxStage Home Hemodialysis Systems are simple, flexible, and portable, enabling more frequent hemodialysis therapy, whether at home or away. 

    MORE FREQUENT HOME HEMODIALYSIS

    SIMPLIFIED DOSING

    Connected Health

    Telehealth platforms that improve patient retention and reduce patient/clinician burden, making it easy to collect and share information.

    LIBERTY® MODEM

    Nx2me CONNECTED HEALTH®

     

    © 2019, Fresenius Medical Care. All Rights Reserved. Fresenius Medical Care, the triangle logo, Liberty, Liberty Select, NxStage, Nx2me Connected Health, and System One are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. All other trademarks are the property of their respective owners. P/N 103965-01 Rev A 10/2019    


News and Announcements
 


What’s Trending on Twitter